Background/Aims: Phenotypic switching of vascular smooth muscle cells (VSMC) plays a vital role in the development of vascular diseases. All-trans retinoic acid (ATRA) is known to regulate VSMC phenotypes. However, the underlying mechanisms remain completely unknown. Here,
Introduction
Vascular proliferative diseases, including atherosclerosis and restenosis after percutaneous coronary interventions, are caused by the combined effects of multiple cell types such as vascular smooth muscle cells (VSMCs), macrophages, and endothelial cells [1] . Inflammation, phenotypic switching, and proliferation of VSMCs are involved in the development of these diseases [2] . Vascular injury, which includes non-denuding endothelial functional injury or denuding endothelial and intimal injury with or without medial damage, represents a critical initiating event in the pathogenesis of various vascular proliferative diseases including restenosis [3] . In response to vascular injury, VSMCs exhibit phenotypic change characterized by a loss of contractility and abnormal proliferation, migration, and matrix synthesis [4] . VSMCs, as the major effector cells in this process, coordinate and synchronize immensely complex inflammatory, proliferative, and differentiation programs [5] . Despite the importance of VSMC phenotypic switching in the development of vascular diseases, the exact mechanisms controlling VSMC phenotypes are not completely understood. Therefore, understanding the molecular mechanisms regulating VSMC phenotypes is helpful for the prevention and treatment of vascular proliferative diseases.
Vasoactive substances and their receptors, cytokines, growth factors, and cellular signaling molecules have been reported to be involved in the regulation of VSMC differentiation, migration, and proliferation [6] [7] [8] . Retinoids are derivatives of vitamin A and are involved in a number of biological processes, including vision, embryogenesis, and differentiation of blood, skin, and tumor cells [9] . Therefore, retinoids are clinically used in oncological treatments, principally against acute promyelocytic leukemia and hyperproliferative skin diseases [10] . Moreover, it was found that retinoids could inhibit inflammation, thrombosis, platelet adhesion and aggregation, and stimulate fibrinolysis [11] . Predominantly, all-trans retinoic acid (ATRA) and its stereoisomer 9-cis retinoic acid (9cRA) were found to be very potent metabolites of retinol, exerting pleiotropic effects on many different biological processes [12] . These effects are mediated by binding to retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which are ligand-dependent transcription factors that belong to the nuclear receptor superfamily [13] . Previous in vitro studies have shown that ATRA inhibits platelet-derived growth factor-BB and serum-induced SMC growth [14] . These effects were most probably mediated by five of six retinoid receptors that were expressed in these vascular SMCs. In addition, the first in vivo study in rat carotid arteries demonstrated that ATRA reduces neointimal thickening and promotes remodeling after endothelial denudation [15] . There is considerable evidence supporting an important role for ATRA in the maintenance and possible establishment of a SMC-differentiated phenotype. However, the molecular mechanism by which ATRA influences VSMC differentiation remains to be elucidated.
Recent data have indicated that numerous transcription regulators mediate responses to inflammation, proliferation, and differentiation in vascular tissues [16] [17] [18] . Of these transcriptional regulators, the mammalian Krüppel-like factor (KLF) family of zinc finger transcription factors has recently received increasing attention. KLF plays important roles in vasculature and both developmental and pathological vascular processes [19] [20] [21] . The novel zinc finger transcription factor ZNF580, whose protein structure is similar to that of KLF, was initially cloned by our group [22] . The murine homolog of ZNF580, namely, ZFP580, was subsequently cloned in our laboratory and investigated in rats [23] . Bioinformatic analyses revealed that ZFP580 is also a C2H2 (Cys2-His2) zinc-finger protein that contains 172 amino acids, and 97% of the amino acid sequence is consistent with ZNF580. Our previous study has shown that ZFP580 had an anti-apoptotic effect on myocardial ischemia reperfusion injury [24] . The expression of ZFP580 significantly changed in VSMCs with intimal neovascularization. In addition, ZFP580 plays an important regulatory role in EPC-EC differentiation via the eNOS/NO pathway [25, 26] . Therefore, we hypothesized that ZFP580 might play an important role in the process of VSMC phenotypic switching and could be used as a new molecular target for treating such diseases.
Our preliminary experimental results showed that ATRA significantly induces ZFP580 expression and promotes the differentiation process in VSMCs. This study was designed to investigate the probable roles of ZFP580 and underlying mechanisms by which ZFP580 influences ATRA-induced VSMCs differentiation. Our results indicate that the transcription factor ZFP580 plays a vital role in inducing differentiation of VSMCs and thereby provide new insights into the biological functions of retinoids during VSMC phenotypic modulation.
Materials and Methods

Reagents
All-trans retinoic acid (ATRA) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS; origin, USA) was purchased from Capricorn Scientific GmbH (Ebsdorfergrund, Germany). Alexa Fluor 488 phalloidin was purchased from Abcam (Cambridge, UK). Lipofectamine TM 2000 Reagent was purchased from Invitrogen (Carlsbad, CA, USA). Antibodies against RARα, RARβ, RARγ, and SMemb were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-ZFP580, anti-SM22α, anti-SMα-actin, anti-ERK1+ERK2, anti-pERK, anti-p38, anti-p-p38, anti-Akt1/2/3, anti-pAkt1/2/3, anti-proliferating cell nuclear antigen (PCNA), and anti-β-actin were from Abcam. Secondary antibodies were anti-IgG+IgM from mouse and rabbit conjugated with peroxidase (Pierce, Rockford, IL, USA). All sterile cell culture materials were obtained from Greiner (Frickenhausen, Germany), unless stated otherwise.
Cell culture and treatment
VSMCs from the thoracic aorta of Sprague Dawley (SD) rats (5-6 weeks old) were isolated using a standard enzymatic digestion technique [27] . Rats were sacrificed with an overdose of pentobarbital sodium (100 mg/kg) by intraperitoneal injection before the aorta was excised. Cells were cultured and passaged in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS, 100 μg/mL penicillin, and 100 μg/mL streptomycin at 37°C in a humidified atmosphere with 5% CO 2 . A total of 3-8 cell passages were used for all experiments. The growth of VSMC cultures were arrested by incubation in serum-free DMEM 
siRNA-mediated gene silencing
Small-interfering RNA (siRNA) duplexes were designed and synthesized by Sangon Biotech (Shanghai, China) for use in silencing RARα. The siRNA sequences against RARα (si-RARα) were 5′-GCAAGUACACUACGAACAATT-3′ and 5′-UUGUUCGUAGUGUACUUGCTT-3′. The nonspecific siRNA sequences (si-NS) were 5′-UUCUCCGAACGUGUCACGUTT-3′ and 5′-ACGUGACACGUUCGGAGAATT-3′. Cells were transfected with siRNAs using Lipofectamine 
Adenovirus infection of VSMCs
Ad-ZFP580, a recombinant adenovirus encoding ZFP580, was generated by subcloning cDNA encoding the total length of ZFP580 into an adenoviral vector, and the parental adenoviral vector was used as an infection negative control (Ad-NC). In addition, an adenovirus encoding Ad-siZFP580 was used to suppress the expression of ZFP580. The forward and reverse primer sequences were ZFP580 siRNA (5′-ACTCGGACCTCAAGCCCTTTA-3′ and 5′-TAAAGGGCTTGAGGTCCGAGT-3′), and a recombinant adenovirus expressing a scrambled siRNA-ZFP580 (Ad-si-scrambled) was used as a control; each of these constructs were synthesized by GenePharma (Shanghai GenePharma Co., China). Cells cultured at 70-80% confluence were infected with Ad-ZFP580 or Ad-siZFP580 at different multiplicities of infection (150 and 200) for 48 h before further treatment.
Quantitative real-time polymerase chain reaction Total RNA was extracted from VSMCs using TRIzol reagent (Sigma-Aldrich), followed by cDNA synthesis using oligo (dT) and MMLV reverse transcriptase (Takara, Tokyo, Japan). The resulting cDNAs were used as templates for quantitative real-time polymerase chain reaction (Q-PCR) conducted with SYBR Green on an ABI Prism 7900 sequence detection PCR system (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocol. The sequences of these primers are listed in the table 1.
Western blot
Cells samples were homogenized in a radioimmunoprecipitation assay (RIPA) lysis PAGE sample loading buffer (containing 5% 2-mercaptoethanol) and boiled for 10 min. Equal amounts of proteins were loaded in each lane, separated by 6-15% SDS-PAGE, and transferred to polyvinylidene difluoride membranes (0.22 μm; Millipore, Billerica, MA, USA). The membranes were blocked with 5% nonfat milk in Tris-buffered saline containing Tween 20 for 1 h at room temperature and then incubated overnight with anti-ZFP580 antibody ( 
Wound-healing assay
VSMCs were seeded into a six-well plate at a density of 2 × 10 5 cells/well, grown to confluence, and starved for 12 h. The cell monolayer was scratched using a sterile 1000 mL
Gene
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Phalloidin staining and confocal laser scanning microscopy
In triplicated independent experiments, VSMCs stimulated with ATRA (20 μmol/L) or transfected with adenovirus were incubated in 4-well chamber slides for 24 h at 37°C with 5% CO 2 . The cells were fixed with 4% paraformaldehyde for 30 min at room temperature (RT), permeabilized for 30 min with PBS plus 0.01% Triton X-100 for 30 min, and stained with Phalloidin (Abcam) for 1 h at RT followed by three washing steps for 10 min. Confocal microscopy was performed with a Confocal Laser Scanning Microscopy System (Leica, Wetzlar, Germany). Pictures were taken from five optical fields (×20) for each well, and cell shape was analyzed.
Rat carotid artery injury model and morphometric analysis of intimal thickening
Male Sprague Dawley rats (1-2 month-old) provided by the Animal Center of the Academy of Military Medical Sciences (Beijing, China) were used to perform this study. The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication 8th Edition, 2011). The animal experimental protocol was approved by the Animal Care and Use Ethics Committee of the Logistics University of the Chinese People's Armed Police Force. Balloon dilation of the left common carotid artery of male SD rats (250-300 g) was performed as previously described [28] . Briefly, rats were anesthetized by intra-peritoneal injection of pentobarbital sodium (30 mg/kg of bodyweight). A size 2F embolectomy balloon catheter was inserted into the left common carotid via the external carotid artery. Then the inflated balloon was drawn gently toward the external carotid artery. After repeating this procedure three times, the catheter was removed. The injured artery was washed with phosphate-buffered saline and incubated for 20 min with 50 μL of adenoviral vector (1 × 10 9 TU/ml) expressing GFP or ZFP580. SD rats were sacrificed by intraperitoneal injection of ketamine (1 g/kg body weight) and xylazine (100 mg/ kg) at the designated time and arteries were collected for real-time PCR and western blot assays or embedded in paraffin or OCT to be prepared into cross-sections. Vessel sections were analyzed by hematoxylin/eosin staining with a computer-based Image-Pro Morphometric System in a double-blind manner. The area of the residual lumen, the area circumscribed by the internal elastic lamina, and the area bounded by the external elastic lamina were measured directly. The degree of neointimal thickening was assessed using the intimato-media area ratio (I/M) and neointimal area. To detect the vascular cell replication rate in vivo, rats were intraperitoneally injected with bromodeoxyuridine (BrdU; 25 mg/kg) at 18 h and 2 h before being sacrificed. The arteries were perfusion-fixed with 4% paraformaldehyde in PBS under a pressure of 100 mmHg, and the segments were snap-frozen in OCT embedding compound. The cryosections of arterial segments were denatured with 1.5 N HCl and subjected to immunofluorescent staining. For antigen retrieval, deparaffinized formalin-fixed sections were boiled for 10 min in 10 mM sodium citrate (pH 6). Primary antibody (PCNA at 1:100 dilution) was incubated overnight at 4°C in 1% normal goat serum in phosphate buffered saline. Contralateral carotid arteries underwent the entire procedure apart from injury and served as the sham group. Rats in the control group were not subjected to any operation.
Statistical analysis
All data are presented as means ± SEM (standard error of the mean) of at least three independent experiments. Comparisons between groups were analyzed by two-tailed Student's t-test or ANOVA procedures. Differences were considered statistically significant at a threshold of P < 0.05 or P < 0.01.
Results
ATRA inhibits cell proliferation and migration while promoting differentiation of VSMCs
To profile the effects of ATRA on VSMC phenotype modulation and biological behaviors, cells were incubated with different concentrations of ATRA (0, 5, 10, 20 μmol/L) for 24 h or with ATRA (20 μmol/L) for different time intervals (0, 24, 48, 72 h). Then changes in proliferation, migration, and the expression of marker genes were detected. MTT colorimetric assays (Fig. 1A and B) and cell migration assays (Fig. 1C and D) showed that incubation with ATRA caused a dose-dependent and time-dependent inhibition of VSMC growth and motility. A significant inhibiting effect was observed by treatment with 20 μmol/L of ATRA for 24 h.
We then examined the effect of ATRA on the expression of two VSMC differentiation markers, SM22α and SMα-actin, and the dedifferentiation marker embryonic vascular smooth muscle myosin heavy chain-B (SMemb) by Q-PCR and western blot. Treatment with ATRA increased expression of SM22α and SMα-actin, while decreasing SMemb levels in a dose-dependent ( Fig. 1E and F) and time-dependent ( Fig. 1G and H) manner. These findings suggest that ATRA inhibits cell proliferation and migration while promoting differentiation of VSMCs.
ATRA-induced ZFP580 expression is RARα dependent
ATRA functions by binding to RARs and RXRs, which act as transcription factors when a ligand is bound. There are three types of RARs, namely RARα, RARβ, and RARγ, each of which is encoded by their respective genes. To explore the actual relationship between ZFP580 and RARs in ATRA-stimulated VSMCs, we first examined the expression of ZFP580 and RARs in response to ATRA signaling. ATRA increased the expression of ZFP580 and RARα in a concentration-( Fig. 2A and B) and time-dependent ( Fig. 2C and D) manner. As shown in Fig.  2A -D, 24 h after 20-μmol/L ATRA treatment, ZFP580 and RARα levels were elevated, and this increase was maintained until 72 h after treatment. However, unlike RARα, the expression levels of RARβ and RARγ were little changed by ATRA treatment.
To further define whether RARα mediated the induction of ZFP580 by ATRA or not, we knocked down endogenous RARα by transfecting VSMCs with siRNAs against RARα (si-RARα) or a control (si-NS). Transfection of si-RARα downregulated endogenous RARα expression. Moreover, the induction of ZFP580 by ATRA was significantly reduced in both mRNA and protein levels in the cells with RARα knockdown (Fig. 2E and F) . Furthermore, when VSMCs were treated with a RARα antagonist (Ro41-5253) prior to the addition of ATRA, the blockade of RARα signaling partially reduced the response of RARα to ATRA (Fig.  2 G and H) .
ATRA induces ZFP580 expression via Akt and ERK pathways
To test which signal pathways mediate ZFP580 expression in response to ATRA, we observed the effect of ATRA on the phosphorylation of p38, Akt, and ERK by western blot. As shown in Fig. 3A , the levels of phospho-Akt and phospho-ERK were increased within 15 min and persisted to 1 h after ATRA treatment, whereas p38 phosphorylation was not affected by ATRA under the same experimental conditions. The level of expression of the molecule did not change during this time course. To assess the importance of Akt and ERK signaling in ZFP580 expression, VSMCs were pretreated either with the Akt inhibitor LY294002, the ERK inhibitor PD98059, or the p38 inhibitor SB203580 for 2 h before exposure to ATRA. Pharmacological inhibition of Akt and ERK blocked ATRA-induced increases in ZFP580 levels, whereas inhibition of p38 did not affect the ZFP580 increase induced by ATRA (Fig.  3B) . These results suggest that the Akt and ERK signaling pathways mediate the observed ATRA-induced ZFP580 protein stability in VSMCs. 
The effects of ZFP580 on VSMC phenotypic switching
To explore the role of ZFP580 on VSMC phenotypic switching, VSMCs were infected with an adenovirus encoding ZFP580 or Ad-siRNA to silence ZFP580. The expression of ZNF580 was evaluated by Q-PCR and western blot (Fig. 4 A and B) . Moreover, overexpression of ZFP580 caused a significant increase in mRNA and protein expression of SM22α and SMα-actin and decreased expression of the dedifferentiation marker SMemb compared with the negative control. In contrast, silencing ZFP580 dramatically reduced the expression of SM22α and SMα-actin and increased expression of SMemb (Fig. 4A and B) .
Actin cytoskeleton reorganization plays a key role in regulating VSMC functionality, which, in turn, depends on the expression of its contractile proteins. We therefore sought to determine whether the overexpression or knockdown of ZFP580 affected the formation of stress fibers. ZFP580 overexpression markedly increased the formation of stress fibers. That is, the actin filaments were recruited into thick and long actin bundles by SM22a. Similarly, ATRA stimulation promoted the formation of stress fibers. When ZFP580 was knocked down, the formation of actin stress fibers induced by ATRA was reduced (Fig. 4C) . Quantitative intensity analysis further indicates that ZFP580 promotes the formation of stress fibers in VSMCs (Fig. 4D) .
ZFP580 inhibited proliferation and intimal hyperplasia in vivo
We examined the effect of ZFP580 on arterial walls in vivo using the classic rat carotid artery balloon injury model. The animals were killed on day 14 after treatment, for morphometric analysis of the cross-sections of the injured carotid arteries. Hematoxylin and eosin staining (Fig. 5A) revealed that the carotid arteries infected with the control adenovirus (Ad-NC) exhibited pronounced neointimal formation, while those infected with Ad-ZFP580 had significantly reduced neointimal hyperplasia. Intimal cell proliferation was evaluated with BrdU incorporation 7 days after balloon angioplasty, when the intimal proliferation peaked. The results showed that BrdU-incorporated intimal cells were decreased by approximately 50% in the Ad-ZFP580 transduced arteries compared with the Ad-NC transduced arteries (Fig. 5B) , indicating that ZFP580 inhibited intimal VSMCs proliferation in vivo. The expression of proliferating cell nuclear antigen (PCNA) in rat carotid arteries infected with Ad-ZFP580 or the control adenovirus (Ad-NC) was confirmed by immunohistochemical staining (Fig. 5C ). PCNA and ZFP580 were also evaluated by western blot (Fig. 5D) . These results demonstrated that ZFP580 suppressed the proliferation and neointimal hyperplasia of injured arteries.
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Discussion
KLFs form a large family of transcription factors that share in common a transcriptional activation/repression domain, a nuclear localization signal, and three Krüppel-like zinc fingers [29] . They have important biological functions in cell proliferation, apoptosis, development, and oncogenic processes [19] [20] [21] . The deduced ZNF580 amino acid sequence contains three tandem repeated C2H2-type zinc fingers at the C-terminus, a protein structure that is similar to that of KLFs. ZFP580 has been shown to play a key role in pathological vascular processes; however, its role in VSMC differentiation under pathophysiological conditions remains unclear. Here, we investigated the effect of ZFP580 on VSMC phenotypic switching, function, and its underlying mechanism.
Proper regulation of VSMC differentiation and growth is critical for vasculogenesis and the maintenance of homeostasis of mature vessel walls [2, 4, 5] . Perturbations of the molecular circuitry governing VSMC differentiation and growth are thought to be of central ) and intima-to-media ratio (I/M) (n = 11 for NC, n = 10 for ZFP580). Arrows indicate the internal elastic lamina, whose corrugated appearance is indicative of vasoconstriction. Magnification, ×200. Rat carotid arteries were balloon injured and infected with Ad-ZFP580 or with Ad-NC. Vessel segments were harvested 7 days later for analysis using (B) BrdU, (C) immunohistochemical staining of PCNA, and (D) western blot (in which the parental adenoviral vector was used as an infection negative control. The bar graph indicates the percentage of BrdUpositive cells in the neointima (n = 4 for each group). Scale bar = 100 μm, **P<0.01, *P<0.05, significantly different from values with Ad-NC.
importance in the pathogenesis of atherosclerosis, hypertension, and restenosis after procedural revascularization. The identification of membrane-bound receptors and the delineation of their respective signaling pathways have yielded insight into the mechanisms that control VSMC differentiation and growth and have provided molecular targets for therapy of vascular disease [6] [7] [8] . In recent years, several nuclear receptor binding factors have been shown to regulate VSMC differentiation and growth. The steroid receptor superfamily has been of particular interest in this regard [30] . Steroid receptors are ligandactivated transcription factors that bind discrete cis elements within the regulatory regions of a growing list of target genes. This family of nuclear receptors includes estrogen receptors, the vitamin D receptor, peroxisome proliferator-activated receptors, and retinoid receptors [31] [32] [33] . Retinoids and the receptors they bind are recognized as having an increasingly important role in both cardiovascular development and the response of blood vessels to injury. Retinoids are natural and synthetic derivatives of vitamin A (retinol) [9] . The discovery of all-trans retinoic acid (ATRA) as the carboxylic acid form of vitamin A led to studies that ascribed virtually all of the biological effects of vitamin A to this natural retinoid [12] . Thus, ATRA plays a vital role in normal embryogenesis and in such postnatal processes as skin and epithelial homeostasis, hematopoiesis, and spermatogenesis [34] . An important early discovery was the demonstration that ATRA could promote cellular differentiation in vitro [35] . These findings led to the use of ATRA and other natural and synthetic retinoids for the treatment of cancer [36] . Today, ATRA is a standard therapy for the management of acute promyelocytic leukemia and is in various phases of clinical trials for a number of other hematological and solid tumors [10, 37] . The common mechanisms underlying cancer and cardiovascular diseases (i.e., perturbations in differentiation and growth) suggest that retinoids could also be of therapeutic value in the treatment of certain vascular diseases. A number of in vitro and in vivo studies have shown that ATRA can positively influence VSMC differentiation programs [14, 15] . Consistent with these findings, we shown that ATRA treatment significantly reduced VSMC proliferation and migration in a dose-and timedependent manner. Moreover, VSMCs incubated with ATRA exhibited enhanced expression of the differentiation makers and decreased expression of the dedifferentiation marker. Our results suggest that the ATRA inhibits cell proliferation and migration while promoting differentiation of VSMCs.
ATRA exerts its pleiotropic biological effects through receptor-mediated changes in gene expression, that is, RARα and RXR. The mRNA expression of RARα, RXRα, and RXRβ is ubiquitous, whereas RARβ (central nervous system), RARγ (skeletal muscle precursors and skin and lung epithelia), and RXRγ (skeletal muscle) exhibit tissue-restricted patterns of expression [13, 38] . Studies utilizing cultured SMCs and adult aorta tissue have documented the mRNA expression of all retinoid receptors except for RXRγ [39] . In the present study, we explore the role of RARs and the relationship between ZFP580 and RARs in response to ATRA signaling. In VSMCs, we discovered that treatment with ATRA induced the expression of ZFP580 and RARα. However, there was no significant change in RARβ and RARγ induced by ATRA treatment. Silencing or inhibition of the RARα gene with its antagonist Ro41-5253 abrogated ATRA-induced ZFP580 transcription, indicating that RARα plays a critical role in the induction of ZFP580 by ATRA and cannot be substituted by other RARs. Reports revealed that ATRA can activate multi-signaling pathways, including the MAPK, PI3-kinase/Akt, cAMP-dependent protein kinase A, and protein kinase C pathways. The present study shows that ATRA induced ZFP580 expression via the PI3K/Akt and ERK-mediated signal pathways. These findings indicated that ZFP580 might participate in ATRA-induced VSMC phenotype modulation.
Differentiation of VSMCs is characterized by the appearance of SMC-specific contractile proteins (e.g., SMα-actin, SM22α, and SMemb), the expression of which is restricted to the SMC lineage and required for SMC contraction and regulation of blood pressure under adult physiologic conditions [40] . However, in response to vascular injury or within atherosclerotic lesions, VSMCs exhibit decreased expression of SMC marker proteins and increased migration, proliferation, and the production of extracellular matrix components Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry as well as matrix metalloproteinases [4] . Transcriptional control of VSMC gene expression plays a central role in the control of VSMC phenotypic plasticity. Phenotypic switching is governed by the activity of a transcription factor network. KLFs are a critical component of such networks, which play critical roles in the physiology and pathophysiology of many organ systems, including cardiovascular, respiratory, digestive, hematological, and immune systems [19] [20] [21] . There have been reports that KLF4 promotes VSMC differentiation by increasing SMC marker protein levels [41] . Overexpression of KLF4 inhibits neointimal hyperplasia induced by balloon injury by inhibiting c-Jun expression [42] . Furthermore, it was also reported that ATRA activated SM22a expression through KLF4 binding to its ciselements in an acetylation-dependent manner and inhibited VSMC differentiation [14] . Our previous studies have shown that the novel zinc-finger transcription factor ZFP580 plays important roles in endothelial biology and cardiovascular disease [24] [25] [26] . We then evaluated the role of ZFP580 in VSMC biology using both gain-and loss-of-function analyses. The up-regulation of differentiation markers induced by overexpression of ZFP580 and the increased formation of stress fibers strongly suggest that ZFP580 induces VSMC differentiation. The dedifferentiation marker SMemb was also down-regulated after ZFP580 overexpression and up-regulated by ZFP580 knockdown, indicating that ZFP580 was an inducer of VSMC differentiation. To further define the role of ZFP580 in the control of VSMC phenotypic modulation, we constructed the classic rat carotid artery injury model. We found that ZFP580 overexpression inhibited neointimal hyperplasia.
Conclusion
In conclusion, the present study demonstrates that ZFP580 facilitates ATRA-induced VSMCs differentiation by the RARα-mediated PI3K/Akt and ERK signaling pathways. The present results thus describe a novel mechanism of regulation of ZFP580 by ATRA and RARα, which is vital to understand the biological functions of retinoids during VSMC phenotypic modulation. 
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